NeoDynamics Investor Relations Material
Latest events
Q1 2024
7 May, 2024
Q4 2023
16 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeoDynamics
Access all reports
NeoDynamics AB is a Swedish medical technology company focused on advancing cancer diagnosis and treatment. The company's flagship product, NeoNavia, is an innovative biopsy system designed for precise, ultrasound-guided tissue sampling. Built on patented pulse technology, NeoNavia enables controlled needle insertion and accurate placement within tumors, particularly for diagnosing breast cancer and axillary lymph nodes. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NEOD
Country
🇸🇪 Sweden